https://www.selleckchem.com/TGF-beta.html
The steroid-dependent dose prior to mizoribine was significantly lower in the response group than in the non-response group (p less then 0.05). The Kaplan-Meier analysis revealed that the probability of regression-free survival was significant higher in patients with steroid-dependent dose of less then 0.25 mg/kg/day than in those with steroid-dependent dose of ≥ 0.25 mg/kg/day (p less then 0.05). During a median follow-up of 5.5 years after mizoribine discontinuation, all but one patient did not develop SDNS. High-dose mizoribine may be an att
Like
Comment
Share
